# Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

> **NCT01404936** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 35 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Interferon-2A
- **DRUG:** Adriamycin
- **DRUG:** Bleomycin
- **DRUG:** Velban
- **DRUG:** Dacarbazine

## Key facts

- **NCT ID:** NCT01404936
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2013-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404936, "Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01404936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*